After 18 - 24 months , in terms of treatment failure , the odds ratio for calcium hydroxide vs. formocresol was 1.94 [ 95 % credible interval ( CI ) : 1.11 , 3.25 ] ; 3.38 ( 95 % CI : 1.37 , 8.61 ) for lasers vs. formocresol ; 2.16 ( 95 % CI : 1.12 , 4.31 ) for calcium hydroxide vs. ferric sulfate ; 3.73 ( 95 % CI : 1.27 , 11.67 ) for lasers vs. ferric sulfate ; 0.47 ( 95 % CI : 0.26 , 0.83 ) for MTA vs. calcium hydroxide ; 3.76 ( 95 % CI : 1.39 , 10.08 ) for lasers vs. MTA CONCLUSIONS After 18 - 24 months , formocresol , ferric sulfate , and MTA showed significantly better clinical and radiographic outcomes than calcium hydroxide and laser therapies in primary molar pulpotomies .
CLINICAL SIGNIFICANCE The network meta-analyses showed that MTA is the first choice for primary molar pulpotomies .
However , if treatment cost is an issue , especially when the treated primary molars are going to be replaced by permanent teeth , ferric sulfate may be the choice
OBJECTIVE Pulpotomy is a common procedure to treat asymptomatic reversible pulpitis in primary molars .
The aim of this study is to undertake a systematic review and a network meta- analysis to compare the clinical and radiographic outcomes of different pulpotomy procedures in primary molars .
Comparison of gray mineral trioxide aggregate and diluted formocresol in pulpotomized primary molars: a 6- to 24-month observation.
PURPOSE The purpose of this multisite , multioperator , prospect i ve , r and omized , controlled clinical trial was to evaluate 2-year outcomes of diluted formocresol ( DFC ) compared to gray mineral trioxide aggregate ( GMTA ) as pulpotomy medicaments . METHODS Following the st and ard pulpotomy procedure , the pulp stumps of 252 primary molars in 168 healthy children were r and omly covered with GMTA or DFC . Pulp chambers were filled with Intermediate Restorative Material ( IRM ( ® ) ) and teeth were restored with stainless steel crowns . At each follow-up appointment , the clinical status of the treated tooth was assessed and radiographs were taken . A total of 694 clinical and radiographic evaluations were analyzed . RESULTS Gender , study site , arch type , and tooth type did not influence treatment outcome . At the combined 6- to 24-month follow-up , clinical success in the DFC group was no different than for the GMTA group . Radiographically , a significantly lower success rate was found in the DFC group vs the MTA group at all time points ( P<.01 ) . Dentin bridge formation was observed at a significantly higher frequency among the GMTA group ( P<.01 ) , while internal root resorption was observed at a higher frequency in the DFC group ( P<.01 ) . CONCLUSION At the combined 6- to 24-month follow-up , gray mineral trioxide aggregate demonstrated significantly better radiographic outcomes vs diluted formocresol as pulpotomy medicaments
After 18 - 24 months , in terms of treatment failure , the odds ratio for calcium hydroxide vs. formocresol was 1.94 [ 95 % credible interval ( CI ) : 1.11 , 3.25 ] ; 3.38 ( 95 % CI : 1.37 , 8.61 ) for lasers vs. formocresol ; 2.16 ( 95 % CI : 1.12 , 4.31 ) for calcium hydroxide vs. ferric sulfate ; 3.73 ( 95 % CI : 1.27 , 11.67 ) for lasers vs. ferric sulfate ; 0.47 ( 95 % CI : 0.26 , 0.83 ) for MTA vs. calcium hydroxide ; 3.76 ( 95 % CI : 1.39 , 10.08 ) for lasers vs. MTA CONCLUSIONS After 18 - 24 months , formocresol , ferric sulfate , and MTA showed significantly better clinical and radiographic outcomes than calcium hydroxide and laser therapies in primary molar pulpotomies .
CLINICAL SIGNIFICANCE The network meta-analyses showed that MTA is the first choice for primary molar pulpotomies .
However , if treatment cost is an issue , especially when the treated primary molars are going to be replaced by permanent teeth , ferric sulfate may be the choice
OBJECTIVE Pulpotomy is a common procedure to treat asymptomatic reversible pulpitis in primary molars .
The aim of this study is to undertake a systematic review and a network meta- analysis to compare the clinical and radiographic outcomes of different pulpotomy procedures in primary molars .